Lexaria Bioscience
Quarterly Financials
| Values in thousands | 2024-08-31 | 2024-05-31 | 2024-02-29 | 2023-11-30 |
|---|---|---|---|---|
Revenue | $84 | $84 | $145 | $151 |
Gross Profit | 84 | 84 | 129 | 146 |
EBITDA | -2,203 | -1,727 | -636 | -1,110 |
EBIT | -2,195 | -1,742 | -652 | -1,150 |
Net Income | -2,184 | -1,781 | -649 | -1,179 |
Net Change In Cash | 84 | 84 | 145 | 151 |
Free Cash Flow | -1,961 | -1,288 | -676 | -1,221 |
Cash | 6,499 | 8,459 | 4,705 | 1,954 |
Basic Shares | 13,855 | 10,765 | 9,051 |
Annual Financials
| Values in thousands | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|
Revenue | $464 | $226 | $255 | $722 |
Gross Profit | 459 | 194 | 183 | 547 |
EBITDA | -5,676 | -6,388 | -6,516 | -5,575 |
EBIT | -5,753 | -6,534 | -6,663 | -5,722 |
Net Income | -5,795 | -6,664 | -7,269 | -2,504 |
Net Change In Cash | 464 | 226 | 255 | 722 |
Free Cash Flow | -4,959 | -6,050 | -5,010 | -4,069 |
Cash | 6,499 | 1,352 | 5,813 | 10,917 |
Basic Shares | 12,383 | 6,614 | 5,885 | 4,391 |
